Pfizer

{
  "main_header": {
    "sid": 970356,
    "name": "Pfizer",
    "stock_name": "Pfizer",
    "full_name": "Pfizer Ltd.",
    "name_url": "stocks-analysis/pfizer",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "4,585.00",
    "chg": 61.6,
    "chgp": "1.36%",
    "dir": 1,
    "prev_price": "4,523.40",
    "mcapval": "20,690.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 500680,
    "symbol": "PFIZER",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE182A01018",
    "curr_date": "Feb 02",
    "curr_time": "",
    "bse_nse_vol": "9.77 k",
    "exc_status": "Active",
    "traded_date": "Feb 02, 2026",
    "traded_date_str": "2026 02 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/pfizer-970356-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Pfizer Ltd. is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pfizer-ltd-is-rated-sell-3814080",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/PfizerLtd_mojoScore_3814080.png",
        "date": "2026-02-01 10:10:39",
        "description": "Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 February 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Pfizer Ltd. is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pfizer-ltd-is-rated-sell-3798182",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/PfizerLtd_mojoScore_3798182.png",
        "date": "2026-01-21 10:10:37",
        "description": "Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 January 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Why is Pfizer Ltd. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-pfizer-ltd-fallingrising-3795010",
        "imagepath": "",
        "date": "2026-01-20 00:56:36",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>Pfizer Ltd.'s stock has been on a downward trajectory over the past week, falling by 2.88%, which notably underperforms the Sensex's modest 0.75% decline during the same period. The trend extends over the last month, where the stock has shed 8.16%, significantly more than the Sensex's 1.98% loss. Year-to-date, Pfizer's shares have declined by 6.01%, again underperforming the benchmark index's 2.32% fall. Over the last year, the stock has generated a negative return of 5.64%, contrasting sharply with the Sensex's robust 8.65% gain. Even over a three-year horizon, Pfizer's cumulative return of 12.98% lags behind the Sensex's 36.79%, while over five years, the stock has declined by 5.66% compared to the Sensex's impressive 68.52% rise...."
      },
      {
        "title": "Pfizer Ltd. Edges Down 0.50% Amid Bearish Technical Signals and Mixed Market Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-edges-down-050-amid-bearish-technical-signals-and-mixed-market-returns-3788305",
        "imagepath": "",
        "date": "2026-01-10 14:03:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>5 Jan:</strong> Stock opens at Rs.4,868.35, declines 0.56%</p>\n                    <p><strong>6 Jan:</strong> Death Cross formation signals bearish trend</p>\n                    <p><strong>7 Jan:</strong> Technical momentum shifts further bearish despite 0.42% gain</p>\n                    <p><strong>8 Jan:</strong> Sharp decline of 2.48% amid broader market weakness</p>\n                    <p><strong>9 Jan:</strong> Stock rebounds 1.35% but closes below week open</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.4,868.35</div></div>\n                    <di..."
      },
      {
        "title": "Pfizer Ltd. is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pfizer-ltd-is-rated-sell-3788014",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/PfizerLtd_mojoScore_3788014.png",
        "date": "2026-01-10 10:10:35",
        "description": "Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Pfizer Ltd. Technical Momentum Shifts to Bearish Amid Mixed Market Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-technical-momentum-shifts-to-bearish-amid-mixed-market-returns-3783937",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/PfizerLtd_technicaldot_3783937.png",
        "date": "2026-01-07 08:21:37",
        "description": "Pfizer Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Despite a modest day gain of 0.92%, the stock’s technical indicators reveal a complex picture, with several metrics signalling caution for investors as the company’s mojo grade was downgraded from Hold to Sell on 29 December 2025."
      },
      {
        "title": "Pfizer Ltd. Forms Death Cross, Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-forms-death-cross-signalling-potential-bearish-trend-3783584",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/PfizerLtd_dealthcross_3783584.png",
        "date": "2026-01-06 18:03:35",
        "description": "Pfizer Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a significant technical indicator where the 50-day moving average (DMA) crosses below the 200-DMA. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and raising concerns about the stock's medium to long-term outlook."
      },
      {
        "title": "Pfizer Ltd Declines 3.04% This Week: 2 Key Factors Behind the Slide",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-declines-304-this-week-2-key-factors-behind-the-slide-3779614",
        "imagepath": "",
        "date": "2026-01-03 14:34:00",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>29 Dec 2025:</strong> Stock opens at ₹4,956.75, down 1.84%</p>\n                    <p><strong>30 Dec 2025:</strong> Downgrade to Sell announced; stock closes at ₹4,928.55 (-0.57%)</p>\n                    <p><strong>31 Dec 2025:</strong> Brief recovery with 1.09% gain to ₹4,982.50</p>\n                    <p><strong>2 Jan 2026:</strong> Week closes at ₹4,896.00, down 0.46% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹5,049.50</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">₹..."
      },
      {
        "title": "Pfizer Ltd. Downgraded to Sell Amid Mixed Financials and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pfizer-ltd-downgraded-to-sell-amid-mixed-financials-and-bearish-technicals-3774452",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PfizerLtd_mojoScore_3774452.png",
        "date": "2025-12-30 08:48:34",
        "description": "Pfizer Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 29 Dec 2025. This shift reflects a combination of deteriorating technical indicators, expensive valuation metrics, and subdued long-term growth prospects despite recent positive quarterly financial results."
      }
    ],
    "total": 339,
    "sid": "970356",
    "stock_news_url": "https://www.marketsmojo.com/news/pfizer-970356"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Board Meeting To Consider And Approve The Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025.",
      "datetime": "30-Jan-2026",
      "details": "Pfizer Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve This is to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Monday February 9 2026 inter alia to consider approve and take on record the Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "20-Jan-2026",
      "details": "Intimation regarding change in Senior Management",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "09-Jan-2026",
      "details": "Please find enclosed herewith the certificate confirming compliance with Regulation 74(5) of the SEBI (DP) Regulations 2018 for the quarter ended December 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "09 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Pfizer Ltd. has declared <strong>350%</strong> dividend, ex-date: 09 Jul 25",
          "dt": "2025-07-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Pfizer Ltd. is Rated Sell

2026-02-01 10:10:39

Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 February 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Pfizer Ltd. is Rated Sell

2026-01-21 10:10:37

Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 January 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Why is Pfizer Ltd. falling/rising?

2026-01-20 00:56:36

Recent Price Movement and Market Comparison

Pfizer Ltd.'s stock has been on a downward trajectory over the past week, falling by 2.88%, which notably underperforms the Sensex's modest 0.75% decline during the same period. The trend extends over the last month, where the stock has shed 8.16%, significantly more than the Sensex's 1.98% loss. Year-to-date, Pfizer's shares have declined by 6.01%, again underperforming the benchmark index's 2.32% fall. Over the last year, the stock has generated a negative return of 5.64%, contrasting sharply with the Sensex's robust 8.65% gain. Even over a three-year horizon, Pfizer's cumulative return of 12.98% lags behind the Sensex's 36.79%, while over five years, the stock has declined by 5.66% compared to the Sensex's impressive 68.52% rise....

Read full news article

Pfizer Ltd. Edges Down 0.50% Amid Bearish Technical Signals and Mixed Market Returns

2026-01-10 14:03:06

Key Events This Week

5 Jan: Stock opens at Rs.4,868.35, declines 0.56%

6 Jan: Death Cross formation signals bearish trend

7 Jan: Technical momentum shifts further bearish despite 0.42% gain

8 Jan: Sharp decline of 2.48% amid broader market weakness

9 Jan: Stock rebounds 1.35% but closes below week open

Week Open

Rs.4,868.35

Read full news article

Pfizer Ltd. is Rated Sell

2026-01-10 10:10:35

Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Pfizer Ltd. Technical Momentum Shifts to Bearish Amid Mixed Market Returns

2026-01-07 08:21:37

Pfizer Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Despite a modest day gain of 0.92%, the stock’s technical indicators reveal a complex picture, with several metrics signalling caution for investors as the company’s mojo grade was downgraded from Hold to Sell on 29 December 2025.

Read full news article

Pfizer Ltd. Forms Death Cross, Signalling Potential Bearish Trend

2026-01-06 18:03:35

Pfizer Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a significant technical indicator where the 50-day moving average (DMA) crosses below the 200-DMA. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and raising concerns about the stock's medium to long-term outlook.

Read full news article

Pfizer Ltd Declines 3.04% This Week: 2 Key Factors Behind the Slide

2026-01-03 14:34:00

Key Events This Week

29 Dec 2025: Stock opens at ₹4,956.75, down 1.84%

30 Dec 2025: Downgrade to Sell announced; stock closes at ₹4,928.55 (-0.57%)

31 Dec 2025: Brief recovery with 1.09% gain to ₹4,982.50

2 Jan 2026: Week closes at ₹4,896.00, down 0.46% on the day

Week Open

₹5,049.50

Week Close

₹...

Read full news article

Pfizer Ltd. Downgraded to Sell Amid Mixed Financials and Bearish Technicals

2025-12-30 08:48:34

Pfizer Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 29 Dec 2025. This shift reflects a combination of deteriorating technical indicators, expensive valuation metrics, and subdued long-term growth prospects despite recent positive quarterly financial results.

Read full news article

View All News